glp-1 receptor agonists and cancer risk in adults with obesity Study Finds May Reduce Glucagon-like peptide-1 receptor agonists and
Description
DOI: 10.1016/j.apsb.2021.04.001, Rajput, R., Ghosh, S., Banerjee, S., et al
Notably, these medications are extremely expensive, insurance coverage is variable and the U.S
Real-world observational studies examining clinical data have not identified consistent patterns of increased rates of general vision problems associated with GLP-1 use, though most studies were not specifically designed to detect rare ocular events
Lancet 2023;402:61326.PubMed 94
doi: 10.1111/j.1742-7843.2004.t01-1-pto950502.x
